1. Home
  2. IVVD vs CVGI Comparison

IVVD vs CVGI Comparison

Compare IVVD & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • CVGI
  • Stock Information
  • Founded
  • IVVD 2020
  • CVGI 2000
  • Country
  • IVVD United States
  • CVGI United States
  • Employees
  • IVVD N/A
  • CVGI N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • CVGI Auto Parts:O.E.M.
  • Sector
  • IVVD Health Care
  • CVGI Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • CVGI Nasdaq
  • Market Cap
  • IVVD 63.4M
  • CVGI 58.2M
  • IPO Year
  • IVVD 2021
  • CVGI 2004
  • Fundamental
  • Price
  • IVVD $0.52
  • CVGI $1.76
  • Analyst Decision
  • IVVD Strong Buy
  • CVGI
  • Analyst Count
  • IVVD 3
  • CVGI 0
  • Target Price
  • IVVD $3.85
  • CVGI N/A
  • AVG Volume (30 Days)
  • IVVD 1.2M
  • CVGI 161.2K
  • Earning Date
  • IVVD 08-14-2025
  • CVGI 08-04-2025
  • Dividend Yield
  • IVVD N/A
  • CVGI N/A
  • EPS Growth
  • IVVD N/A
  • CVGI N/A
  • EPS
  • IVVD N/A
  • CVGI N/A
  • Revenue
  • IVVD $46,210,000.00
  • CVGI $676,815,000.00
  • Revenue This Year
  • IVVD $345.16
  • CVGI N/A
  • Revenue Next Year
  • IVVD $161.08
  • CVGI $7.37
  • P/E Ratio
  • IVVD N/A
  • CVGI N/A
  • Revenue Growth
  • IVVD 1941.08
  • CVGI N/A
  • 52 Week Low
  • IVVD $0.35
  • CVGI $0.81
  • 52 Week High
  • IVVD $2.74
  • CVGI $3.81
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 32.49
  • CVGI 47.92
  • Support Level
  • IVVD $0.48
  • CVGI $1.70
  • Resistance Level
  • IVVD $0.65
  • CVGI $1.94
  • Average True Range (ATR)
  • IVVD 0.06
  • CVGI 0.13
  • MACD
  • IVVD -0.03
  • CVGI -0.01
  • Stochastic Oscillator
  • IVVD 11.35
  • CVGI 36.67

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

Share on Social Networks: